by Suzannah Cavanaugh | Oct 2, 2020
Moderna Inc. announced Tuesday that its Covid-19 vaccine candidate had generated levels of virus-neutralizing antibodies in older adults on par with those produced in younger trial participants, a crucial step towards approval. The early-stage result gives Moderna a...
by Suzannah Cavanaugh | Sep 18, 2020
Antitrust suits weigh on sinking big tech After soaring to record highs in August, shares of big tech stocks have driven markets lower this month as developing antitrust cases against four tech mega-caps stoke fears about the sector’s long-term viability. The...